Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Beauchamp

Showing results (231-240 of 244) with videos related to

Pageof 25
Sort By:
Neuro-Oncology Advances|May 22, 2023
Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2Justin T Jordan, Christina C Orr, Raquel D Thalheimer, et al.
Investigative Ophthalmology & Visual Science|December 22, 2021
Reach Kinematics During Binocular Viewing in 7- to 12-Year-Old Children With StrabismusKrista R Kelly, Jeffrey Hunter, Dorsa Mir Norouzi, et al.
Analytical Chemistry|February 21, 2012
Designer reagents for mass spectrometry-based proteomics: clickable cross-linkers for elucidation of protein structures and interactionsChang Ho Sohn, Heather D Agnew, J Eugene Lee, et al.
Molecular Therapy. Methods & Clinical Development|May 15, 2024
Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2Shilpa Prabhakar, Roberta L Beauchamp, Pike See Cheah, et al.
Molecular Therapy. Methods & Clinical Development|July 18, 2022
Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2Shilpa Prabhakar, Roberta L Beauchamp, Pike See Cheah, et al.
Science Advances|February 1, 2021
Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberinPike-See Cheah, Shilpa Prabhakar, David Yellen, et al.
Neuro-Oncology|July 9, 2018
EPH receptor signaling as a novel therapeutic target in NF2-deficient meningiomaSteven P Angus, Janet L Oblinger, Timothy J Stuhlmiller, et al.
International Journal of Obesity (2005)|November 21, 2017
Diet-resistant obesity is characterized by a distinct plasma proteomic signature and impaired muscle fiber metabolismA B Thrush, G Antoun, M Nikpay, et al.
Scientific Reports|August 24, 2021
High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathyChialin Cheng, Surya A Reis, Emily T Adams, et al.
American Journal of Respiratory and Critical Care Medicine|October 14, 2016
DJ-1/PARK7 Impairs Bacterial Clearance in SepsisHajera Amatullah, Yuexin Shan, Brittany L Beauchamp, et al.
Pageof 25

Showing results (231-240 of 244) with videos related to

Sort By:
Pageof 25
Neuro-Oncology Advances|May 22, 2023
Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2Justin T Jordan, Christina C Orr, Raquel D Thalheimer, et al.
Investigative Ophthalmology & Visual Science|December 22, 2021
Reach Kinematics During Binocular Viewing in 7- to 12-Year-Old Children With StrabismusKrista R Kelly, Jeffrey Hunter, Dorsa Mir Norouzi, et al.
Analytical Chemistry|February 21, 2012
Designer reagents for mass spectrometry-based proteomics: clickable cross-linkers for elucidation of protein structures and interactionsChang Ho Sohn, Heather D Agnew, J Eugene Lee, et al.
Molecular Therapy. Methods & Clinical Development|May 15, 2024
Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2Shilpa Prabhakar, Roberta L Beauchamp, Pike See Cheah, et al.
Molecular Therapy. Methods & Clinical Development|July 18, 2022
Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2Shilpa Prabhakar, Roberta L Beauchamp, Pike See Cheah, et al.
Science Advances|February 1, 2021
Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberinPike-See Cheah, Shilpa Prabhakar, David Yellen, et al.
Neuro-Oncology|July 9, 2018
EPH receptor signaling as a novel therapeutic target in NF2-deficient meningiomaSteven P Angus, Janet L Oblinger, Timothy J Stuhlmiller, et al.
International Journal of Obesity (2005)|November 21, 2017
Diet-resistant obesity is characterized by a distinct plasma proteomic signature and impaired muscle fiber metabolismA B Thrush, G Antoun, M Nikpay, et al.
Scientific Reports|August 24, 2021
High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathyChialin Cheng, Surya A Reis, Emily T Adams, et al.
American Journal of Respiratory and Critical Care Medicine|October 14, 2016
DJ-1/PARK7 Impairs Bacterial Clearance in SepsisHajera Amatullah, Yuexin Shan, Brittany L Beauchamp, et al.
Pageof 25